https://nymag.com/ One Saturday afternoon in the fall of 2016, Dr. Sally Smith received a call from the pediatric emergency room at Johns Hopkins All Children’s Hospital in St. Petersburg, Florida. Smith Read More
CTInsider article:Jayesh Kamath said the use of ketamine therapies for treatment of depression could be “groundbreaking.” “We’ve been stuck with antidepressants for decades,” he said. Kamath is a professor of psychiatry at Read More
Article from Psychiatry Advisor: Ketamine was originally approved by the US Food and Drug Administration (FDA) as an anesthetic, but is increasingly being used to treat mood disorders, such as treatment-resistant Read More
(HealthDay News) — A new clinical trial strengthens the case that ketamine — once famous as a club drug — can rapidly ease suicidal thoughts. Researchers found that among 156 adults Read More
Researchers at Cincinnati Children’s Hospital Medical Center have concluded that intranasal ketamine is as effective as intranasal fentanyl for the relief of pain from acute extremity injury in children. The Read More
The results of a new clinical trial with ketamine were published in Nature’s Molecular Psychiatry journal. Researchers conducted a double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant Read More
The National Institute of Mental Health (NIMH) issued a highlight on ketamine for treating depression. The most commonly used antidepressants are largely variations on a theme; they increase the supply within synapses of Read More
Researchers from the University of Minnesota and The Mayo Clinic found that ketamine caused an average decrease of 42% on the Children’s Depression Rating Scale(CDRS)—the most widely used rating scale in Read More
Researchers at Yale published a new study titled “Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital” in Clinical Psychiatry. In late 2014, Yale began Read More
CNN featured a segment on the use of ketamine for treating suicidal ideation–a novel, off-label use for ketamine that is currently being explored in human clinical trials. The segment featured Dr. Read More
Neuropathic pain is notoriously difficult to treat. Patients are often treated as regular chronic pain patients and many resort to opioids to manage extreme levels of pain. Neuropathic pain can Read More
Australian researchers completed the world’s first randomized control trial (RCT), assessing the efficacy and safety of ketamine as a treatment for depression in elderly patients. In this double-blind, controlled, multiple-crossover study Read More
It’s been more than two years now since the former director of the National Institute of Mental Health wrote about the use of intravenous ketamine for the treatment of mental Read More
PTSD Treatment – Ketamine is a novel treatment for several psychiatric disorders including: Major Depressive Disorder, Bipolar Depression, Postpartum Depression, Obsessive-Compulsive Disorder (OCD), and Posttraumatic Stress Disorder or PTSD. It Read More
Good news for patients suffering from Chronic Migraine or new daily persistent headache. A retrospective review of 77 patients who underwent administration of intravenous, subanesthetic ketamine was conducted by investigators Read More
Complex Regional Pain Syndrome (CRPS) is an extremely painful neuropathic pain condition that is notoriously hard to treat. At present, there are no FDA-approved medications that are indicated for treating Read More